Annual Net Income
-$14.29 M
+$98.38 M+87.32%
December 31, 2023
Summary
- As of February 26, 2025, APRE annual net profit is -$14.29 million, with the most recent change of +$98.38 million (+87.32%) on December 31, 2023.
- During the last 3 years, APRE annual net income has risen by +$39.19 million (+73.29%).
- APRE annual net income is now -183064.10% below its all-time high of -$7800.00, reached on December 1, 2004.
Performance
APRE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$3.78 M
-$313.70 K-9.04%
September 30, 2024
Summary
- As of February 26, 2025, APRE quarterly net profit is -$3.78 million, with the most recent change of -$313.70 thousand (-9.04%) on September 30, 2024.
- Over the past year, APRE quarterly net income has dropped by -$973.70 thousand (-34.65%).
- APRE quarterly net income is now -54.94% below its all-time high of -$2.44 million, reached on December 31, 2022.
Performance
APRE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$13.51 M
-$579.30 K-4.48%
September 30, 2024
Summary
- As of February 26, 2025, APRE TTM net profit is -$13.51 million, with the most recent change of -$579.30 thousand (-4.48%) on September 30, 2024.
- Over the past year, APRE TTM net income has dropped by -$790.30 thousand (-6.21%).
- APRE TTM net income is now -330.40% below its all-time high of -$3.14 million, reached on September 30, 2018.
Performance
APRE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
APRE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.3% | -34.6% | -6.2% |
| 3 y3 years | +73.3% | +60.0% | +69.8% |
| 5 y5 years | +8.0% | +39.5% | +51.9% |
APRE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.3% | -54.9% | +96.2% | -6.2% | +89.0% |
| 5 y | 5-year | at high | +87.3% | -54.9% | +96.2% | -6.2% | +89.0% |
| alltime | all time | <-9999.0% | +87.3% | -54.9% | +96.2% | -330.4% | +89.0% |
Aprea Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.78 M(+9.0%) | -$13.51 M(+4.5%) |
| Jun 2024 | - | -$3.47 M(+23.5%) | -$12.93 M(+1.7%) |
| Mar 2024 | - | -$2.81 M(-18.4%) | -$12.72 M(-11.0%) |
| Dec 2023 | -$14.29 M(-87.3%) | -$3.44 M(+7.5%) | -$14.29 M(+7.5%) |
| Sep 2023 | - | -$3.20 M(-1.7%) | -$13.29 M(-5.8%) |
| Jun 2023 | - | -$3.26 M(-25.6%) | -$14.11 M(-87.1%) |
| Mar 2023 | - | -$4.38 M(+79.3%) | -$109.11 M(-3.2%) |
| Dec 2022 | -$112.66 M(+203.4%) | -$2.44 M(-39.3%) | -$112.66 M(-4.5%) |
| Sep 2022 | - | -$4.02 M(-95.9%) | -$117.98 M(-4.4%) |
| Jun 2022 | - | -$98.26 M(+1138.0%) | -$123.40 M(+248.6%) |
| Mar 2022 | - | -$7.94 M(+2.3%) | -$35.40 M(-4.7%) |
| Dec 2021 | -$37.13 M(-30.6%) | -$7.76 M(-18.0%) | -$37.13 M(-17.1%) |
| Sep 2021 | - | -$9.45 M(-7.8%) | -$44.76 M(-6.0%) |
| Jun 2021 | - | -$10.25 M(+6.0%) | -$47.63 M(-11.4%) |
| Mar 2021 | - | -$9.67 M(-37.2%) | -$53.75 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$53.48 M(+90.6%) | -$15.39 M(+25.0%) | -$53.48 M(+4.5%) |
| Sep 2020 | - | -$12.32 M(-24.7%) | -$51.16 M(+13.5%) |
| Jun 2020 | - | -$16.37 M(+74.1%) | -$45.09 M(+32.7%) |
| Mar 2020 | - | -$9.40 M(-28.1%) | -$33.98 M(+21.1%) |
| Dec 2019 | -$28.06 M(+80.7%) | -$13.07 M(+109.2%) | -$28.06 M(+42.7%) |
| Sep 2019 | - | -$6.25 M(+18.8%) | -$19.67 M(+18.8%) |
| Jun 2019 | - | -$5.26 M(+51.4%) | -$16.56 M(+46.6%) |
| Mar 2019 | - | -$3.48 M(-25.7%) | -$11.29 M(+44.5%) |
| Dec 2018 | -$15.53 M(+2.2%) | -$4.68 M(+49.1%) | -$7.82 M(+149.1%) |
| Sep 2018 | - | -$3.14 M | -$3.14 M |
| Dec 2017 | -$15.19 M(+331.0%) | - | - |
| Jun 2008 | -$3.52 M(-41.4%) | - | - |
| Jun 2007 | -$6.02 M(-39.1%) | - | - |
| Jun 2006 | -$9.88 M(>+9900.0%) | - | - |
| Dec 2004 | -$7800.00 | - | - |
FAQ
- What is Aprea Therapeutics annual net profit?
- What is the all time high annual net income for Aprea Therapeutics?
- What is Aprea Therapeutics annual net income year-on-year change?
- What is Aprea Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly net income year-on-year change?
- What is Aprea Therapeutics TTM net profit?
- What is the all time high TTM net income for Aprea Therapeutics?
- What is Aprea Therapeutics TTM net income year-on-year change?
What is Aprea Therapeutics annual net profit?
The current annual net income of APRE is -$14.29 M
What is the all time high annual net income for Aprea Therapeutics?
Aprea Therapeutics all-time high annual net profit is -$7800.00
What is Aprea Therapeutics annual net income year-on-year change?
Over the past year, APRE annual net profit has changed by +$98.38 M (+87.32%)
What is Aprea Therapeutics quarterly net profit?
The current quarterly net income of APRE is -$3.78 M
What is the all time high quarterly net income for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly net profit is -$2.44 M
What is Aprea Therapeutics quarterly net income year-on-year change?
Over the past year, APRE quarterly net profit has changed by -$973.70 K (-34.65%)
What is Aprea Therapeutics TTM net profit?
The current TTM net income of APRE is -$13.51 M
What is the all time high TTM net income for Aprea Therapeutics?
Aprea Therapeutics all-time high TTM net profit is -$3.14 M
What is Aprea Therapeutics TTM net income year-on-year change?
Over the past year, APRE TTM net profit has changed by -$790.30 K (-6.21%)